Total trials
223
Active
52
Phase 3
5
Total enrollment
28,038
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Semaglutide | — | — | — | — | — | 2 | |
| Botulinum Toxin Type A | — | — | — | — | 4 | ||
| Denosumab 60 mg/ml | — | — | — | — | — | 1 | |
| fluticasone furoate(FF)/umeclidinium (UMEC)/vilanterol(VI) (100/62.5/25) mcg | — | — | — | — | — | 1 | |
| Redesca | — | — | — | — | — | 1 | |
| Fragmin | — | — | — | — | — | 1 | |
| Fecal microbial transplant | — | — | — | — | — | 1 | |
| 75 mg of oral ketamine | — | — | — | — | — | 1 | |
| Sublingual ketamine 75 mg | — | — | — | — | — | 1 | |
| Lipiodal | — | — | — | — | — | 1 | |
| Psilocybin | — | — | — | — | — | 1 | |
| Biologic Therapy | — | — | — | — | — | 1 |
Next readouts
- 2025-02-01
- 2025-07-01
- 2025-09
- 2025-12
- 2026-03-30
- 2026-09-30
- 2027-03-30
- 2027-08-01
- 2027-09
- 2029-05-01
Top conditions
- Sedentary Lifestyle8
- Health Behaviour Change5
- Head and Neck Cancer4
- Functional Movement Disorder4
- Parkinson Disease4
- Ketosis4
- Osteoarthritis3
- Overweight3
Frequently asked questions about Western University, Canada
- How many clinical trials does Western University, Canada have on ClinicalTrials.gov?
- Western University, Canada is listed as the lead sponsor on 223 clinical trials in ClinicalTrials.gov, 52 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Western University, Canada's trials are in Phase 3?
- 5 of Western University, Canada's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does Western University, Canada focus on?
- Western University, Canada's most-studied conditions on ClinicalTrials.gov are Sedentary Lifestyle, Health Behaviour Change, Head and Neck Cancer, Functional Movement Disorder, Parkinson Disease.
- When are Western University, Canada's next clinical trial readouts?
- Western University, Canada has 10 upcoming primary-completion readouts tracked here; the soonest is “Prolonged Hypercoagulability Following Major Liver Resection for Malignancy”, expected around 2025-02-01.